Soluble Urokinase Receptor and Acute Kidney Injury
Salim S. Hayek(Rush University Medical Center), Jochen Reiser(The University of Texas Medical Branch at Galveston), David E. Leaf(Brigham and Women's Hospital), Sanja Sever(Harvard University), Steven D. Weisbord(University of Pittsburgh), Jenny S. Pan(University of Pittsburgh), Michael W. Holliday(Brigham and Women's Hospital), Alexander Camacho(Brigham and Women's Hospital), James L. Januzzi(Harvard University), Shreyak Sharma(Brigham and Women's Hospital), Ranadheer R. Dande(Brigham and Women's Hospital), Sushrut S. Waikar(Metabolism and Renal Physiology), Changli Wei(Rush University Medical Center), Nasrien E. Ibrahim, Mehmet M. Altintas(The University of Texas Medical Branch at Galveston), Rebecca M. Baron(Brigham and Women's Hospital), Xuexiang Wang(Soochow University), Arshed A. Quyyumi(Emory University), Mohamad Raad(Brigham and Women's Hospital), Ayman Samman Tahhan(Emory University), David Sheikh‐Hamad(Baylor College of Medicine)
Cited by 204
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
|The American Journal of Cardiology|2005|1.2k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834